Product Images Abacavir And Lamivudine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Abacavir And Lamivudine NDC 70771-1053 by Zydus Lifesciences Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
26926cd8 65cb 49c4 8e97 b5b81ec247f0 03
This is a prescription drug information sheet for Abacavir and Lamivudine tablets in 600mg/300mg strength. It contains dosage instructions and a warning to keep the drug out of reach of children. The image may also show the number of tablets in the package.*
26926cd8 65cb 49c4 8e97 b5b81ec247f0 04
This is a warning card for Abacavir and Lamivudine Tablets, USP which may cause a serious allergic reaction resulting in death. If you experience symptoms such as fever, rash, nausea, vomiting, diarrhea, abdominal pain, chills, shortness of breath, cough or sore throat, while taking this medication, call your healthcare provider immediately to determine if you should stop taking it. In case of an allergic reaction to abacavir, do not take this medication again or any other medication containing abacavir. The trademark medications containing abacavir are Ziagen, Triumeq and Trizivir. You may experience life-threatening symptoms such as very low blood pressure or death within hours after taking it again. Please refer to the Medication Guide for further information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.